NUTX vs. AMWL, DHX, RSSS, HGBL, MNY, STCN, SWVL, SCOR, SGRP, and MCHX
Should you be buying Nutex Health stock or one of its competitors? The main competitors of Nutex Health include American Well (AMWL), DHI Group (DHX), Research Solutions (RSSS), Heritage Global (HGBL), MoneyHero (MNY), Steel Connect (STCN), Swvl (SWVL), comScore (SCOR), SPAR Group (SGRP), and Marchex (MCHX). These companies are all part of the "business services, not elsewhere classified" industry.
American Well (NYSE:AMWL) and Nutex Health (NASDAQ:NUTX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.
Nutex Health has a net margin of -15.85% compared to Nutex Health's net margin of -137.32%. American Well's return on equity of -44.06% beat Nutex Health's return on equity.
In the previous week, Nutex Health had 6 more articles in the media than American Well. MarketBeat recorded 8 mentions for Nutex Health and 2 mentions for American Well. American Well's average media sentiment score of 1.13 beat Nutex Health's score of 0.55 indicating that Nutex Health is being referred to more favorably in the news media.
Nutex Health has lower revenue, but higher earnings than American Well. Nutex Health is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.
56.1% of American Well shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 12.8% of American Well shares are owned by company insiders. Comparatively, 38.5% of Nutex Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
American Well currently has a consensus target price of $0.80, indicating a potential upside of 87.40%. Nutex Health has a consensus target price of $15.00, indicating a potential upside of 2,097.80%. Given American Well's stronger consensus rating and higher probable upside, analysts clearly believe Nutex Health is more favorable than American Well.
American Well has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, Nutex Health has a beta of 0.29, suggesting that its share price is 71% less volatile than the S&P 500.
American Well received 26 more outperform votes than Nutex Health when rated by MarketBeat users. However, 100.00% of users gave Nutex Health an outperform vote while only 47.06% of users gave American Well an outperform vote.
Summary
Nutex Health beats American Well on 12 of the 18 factors compared between the two stocks.
Get Nutex Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for NUTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NUTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nutex Health Competitors List
Related Companies and Tools
